Gastroenterologists will begin receiving education visits later in June under the government’s Value in Prescribing program to encourage best practice in treating IBD with bDMARDs. The Targeted Therapies Alliance, which includes GESA among its stakeholders, does not plan at this point to delve into the prescribing patterns of individual practitioners as it did with rheumatologists ...
‘Value in prescribing’ visits in store for clinicians using bDMARDs
By Julie Lambert
1 Jun 2021